Gemini bioproducts:1110293 [15-010774]
Ended Awarded Last action
- Contract number
- HHSN26500001
- Awardee
-
Gemini Bioproducts LLC UEI TPLGWKT6AM88
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,244
Award facts
- Contract value 100% obligated
- $24,244.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Broderick, CA 95605, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$642 | |
| Original award | $24,886 |
About this award
Gemini Bioproducts LLC, a West Sacramento, California-based supplier of cell culture products and scientific reagents, was awarded a Blanket Purchase Agreement (BPA) call valued at $24,244.00 by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health. The contract, issued August 11, 2015, with an ultimate completion date of May 31, 2016, carried firm fixed-price terms with no set-aside designation. This award represents a task order against one of Gemini Bioproducts' significant existing indefinite delivery/indefinite quantity (IDIQ) contracts—a $100 million BPA with the Office of Logistics and Acquisition Operations that provides cell culture products, sera, antibiotics, media, reagents, and blood-related products to federal research institutions.
As a long-established supplier registered in SAM.gov since 2001, Gemini Bioproducts has maintained a consistent track record of providing critical biological materials to NIH institutes and other federal agencies supporting biomedical research. The company's product portfolio of fetal bovine serum, specialized cell culture media, and other scientific reagents is essential to the research missions of institutes such as NINDS, which focuses on neurological disorders and stroke research. This BPA call award exemplifies the company's strategic role in supplying high-quality materials to support federal research initiatives across multiple disease areas and research priorities.
Quick answers
Who was awarded contract HHSN26500001?
HHSN26500001 was awarded to Gemini Bioproducts LLC by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on August 11, 2015.
How much is contract HHSN26500001 worth?
The government has obligated $24,244 on HHSN26500001.
Is contract HHSN26500001 an order under another contract?
Yes. HHSN26500001 is a BPA call under HHSN263201500189B, a blanket purchase agreement.
Was contract HHSN26500001 competed?
The extent of competition for HHSN26500001 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award